![mikrobit_1.jpg](/493482/globalassets/01-common-images/section-landing-page-hero-images/microbes/mikrobit_1.jpg?w=320&h=180&mode=DownFill&hash=bcef50bc4e36318954cacd0e3e58531e)
![Orion_nosto2.png](/4acf1c/globalassets/investors/pictures/orion_nosto2.png?w=320&h=180&mode=DownFill&hash=bcef50bc4e36318954cacd0e3e58531e)
Investors
This section contains information about Orion as an investment.
Stock exchange releases
- 7/1/2024 Inside information: Orion upgrades full-year outlook for 2024
- 7/1/2024 Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- 5/7/2024 Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025
- 4/26/2024 Composition of the Nomination Committee of Orion Corporation
Press releases
- 6/3/2024 Orion is developing the Finnish life science industry in a unique collaboration project
- 4/11/2024 Orion publishes Interim Report for January–March 2024 and holds a webcast on 25 April 2024
- 3/22/2024 The change negotiations concerning Orion’s Kuopio plant have been concluded – the company has decided to continue to explore the outsourcing of production at the plant
- 2/22/2024 Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally